Fuller (NYSE: FUL) CFO granted 191.78 phantom units at $65.72

Rhea-AI Filing Summary

FULLER H B CO Executive VP and CFO John J. Corkrean reported an equity-based compensation grant. On February 27, 2026, he acquired 191.78 Phantom Units at $65.72 per unit as a grant, not an open-market purchase.

According to footnotes, these phantom units convert into common stock on a 1-for-1 basis, generally upon certain termination events or an earlier date selected under the Key Employee Deferred Compensation Plan, subject to legal holding periods. After this grant, Corkrean held 32,612 Phantom Units.

The filing also updates direct holdings of various employee stock options, restricted stock units that vest in three annual installments of 33%, 33%, and 34%, and direct common stock holdings, reflecting his overall equity-based compensation position in the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Corkrean John J

(Last) (First) (Middle)

1200 WILLOW LAKE BOULEVARD

P.O. BOX 64683

(Street)

ST. PAUL MN 55164-0683

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								59,508	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Units	$0.0000(1)	02/27/2026		A		191.78		(2)	(2)	Common Stock	191.78	$65.72	32,612(3)	D
Employee Stock Option (Right-to-Buy)	$45.05							01/24/2020(4)	01/24/2029	Common Stock	41,208		41,208	D
Employee Stock Option (Right-to-Buy)	$48.35							01/24/2021(4)	01/24/2030	Common Stock	48,309		48,309	D
Employee Stock Option (Right-to-Buy)	$50.1							01/26/2018(4)	01/26/2027	Common Stock	23,696		23,696	D
Employee Stock Option (Right-to-Buy)	$51.89							01/27/2022(4)	01/27/2031	Common Stock	38,376		38,376	D
Employee Stock Option (Right-to-Buy)	$53.57							01/25/2019(4)	01/25/2028	Common Stock	21,834		21,834	D
Employee Stock Option (Right-to-Buy)	$59.81							01/26/2027(5)	01/26/2036	Common Stock	39,347		39,347	D
Employee Stock Option (Right-to-Buy)	$64.28							01/27/2026(5)	01/27/2035	Common Stock	24,570		24,570	D
Employee Stock Option (Right-to-Buy)	$68.17							01/24/2024(4)	01/24/2033	Common Stock	22,312		22,312	D
Employee Stock Option (Right-to-Buy)	$72.94							01/24/2023(4)	01/24/2032	Common Stock	21,997		21,997	D
Employee Stock Option (Right-to-Buy)	$77.72							01/26/2025(5)	01/26/2034	Common Stock	24,774		24,774	D
Restricted Stock Units	$0.0000(6)							01/26/2025(7)	01/26/2027	Common Stock	1,453.86		1,453.86(8)	D
Restricted Stock Units	$0.0000(6)							01/26/2027(7)	01/26/2029	Common Stock	5,824.9		5,824.9	D
Restricted Stock Units	$0.0000(6)							01/27/2026(7)	01/27/2028	Common Stock	2,940.13		2,940.13(8)	D

Explanation of Responses:

1. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.

2. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.

3. Amount includes stock units acquired pursuant to a dividend equivalent feature.

4. This option is 100% vested.

5. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

6. These restricted stock units convert into shares of common stock on a 1-for-1 basis.

7. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

8. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.

	/s/ Patrick J. Seul, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FUL Executive VP and CFO John J. Corkrean report in this Form 4?

John J. Corkrean reported receiving a grant of 191.78 Phantom Units as equity-based compensation. These units are part of his overall long-term incentives and are separate from regular common stock and option holdings disclosed in the same report.

How many Phantom Units did FUL’s CFO acquire and at what reference price?

Corkrean acquired 191.78 Phantom Units at a reference price of $65.72 per unit. The transaction is classified as a grant or award, not an open-market buy, and increases his Phantom Unit balance reported after the transaction.

How do the Phantom Units reported by FUL’s CFO convert into common stock?

The Phantom Units convert into shares of FULLER H B CO common stock on a 1-for-1 basis. Conversion generally occurs upon specified termination events or an earlier date chosen under the Key Employee Deferred Compensation Plan, subject to required legal holding periods.

What was John J. Corkrean’s Phantom Unit balance after this Form 4 transaction for FUL?

After the reported grant, Corkrean held 32,612 Phantom Units. This figure reflects the updated balance following the 191.78-unit award and represents deferred equity compensation linked to the company’s common stock on a one-for-one basis.

Does this FUL Form 4 show any open-market stock purchases or sales by the CFO?

The Form 4 classifies the reported 191.78 Phantom Units as a grant or award acquisition, not an open-market trade. Other entries in the filing update holdings of options, restricted stock units, and common stock without specifying additional buy or sell transactions.

What other equity awards or holdings for FUL’s CFO are updated in this Form 4?

The filing updates balances for several Employee Stock Options and Restricted Stock Units, many of which vest in three annual installments of 33%, 33%, and 34%. It also reports Corkrean’s direct common stock holdings after the reported transactions on February 27, 2026.